PINION JOHN RICHARD (See Remarks) sold 4.5% of their position (3.75K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $170.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2023ACC: 0001209191-23-016042
Officer· See Remarks
Since Mar 2026
+56.29K
Net shares
Net buyer
$353.2K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
64.06K acquired · 7.77K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+2.66K
Price / share
—
Trade value
—
% of position
4.5%
3/1/2023
59.27K→61.93K
Common Stock
Direct
Shares
+22K
Price / share
—
Trade value
—
% of position
35.5%
3/1/2023
61.93K→83.93K
Common Stock
Direct
Shares
−3.75K
Price / share
$45.26
Trade value
$169.95K
% of position
4.5%
3/1/2023
83.93K→80.17K
Common Stock
Direct
Shares
−4.01K
Price / share
$45.65
Trade value
$183.24K
% of position
5.0%
3/1/2023
80.17K→76.16K
Total
Net shares
+16.89K
Net value
-$353.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2023 | A · Award | +2.66K | — | — | 4.5% | 59.27K | 61.93K |
| Common Stock Direct | 3/1/2023 | A · Award | +22K | — | — | 35.5% | 61.93K | 83.93K |
| Common Stock Direct | 3/1/2023 | S · Sale | −3.75K | $45.26 | $169.95K | 4.5% | 83.93K | 80.17K |
| Common Stock Direct | 3/1/2023 | D · Disposition | −4.01K | $45.65 | $183.24K | 5.0% | 80.17K | 76.16K |
| Total | +16.89K | -$353.19K | ||||||
Derivative Transactions1
3/1/2023
Direct
Converts to
Common Stock
39.40K shares
Shares
+39.40K
Strike price
45.65
Held after
39.40K
Exercisable
—
3/1/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| 3/1/2023 Direct | Common Stock39.40K shares | 3/1/2023 | A · Award | +39.40K | 45.65 | — | 39.40K |